Literature DB >> 8390332

Type II autoimmune hepatitis: the conundrum of cytochrome P450IID6.

D Vergani, G Mieli-Vergani.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8390332      PMCID: PMC1554764          DOI: 10.1111/j.1365-2249.1993.tb03406.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  17 in total

1.  Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis.

Authors:  J C Homberg; N Abuaf; O Bernard; S Islam; F Alvarez; S H Khalil; R Poupon; F Darnis; V G Lévy; P Grippon
Journal:  Hepatology       Date:  1987 Nov-Dec       Impact factor: 17.425

2.  Identification of the hepatic asialo-glycoprotein receptor (hepatic lectin) as a component of liver specific membrane lipoprotein (LSP).

Authors:  I G McFarlane; B M McFarlane; G N Major; P Tolley; R Williams
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

3.  Liver cell surface expression of the antigen reacting with liver-kidney microsomal antibody (LKM).

Authors:  M Lenzi; F B Bianchi; F Cassani; E Pisi
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

4.  Cytochrome P450IID6 recognized by LKM1 antibody is not exposed on the surface of hepatocytes.

Authors:  A M Yamamoto; C Mura; C De Lemos-Chiarandini; R Krishnamoorthy; F Alvarez
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

5.  Liver membrane autoantibodies in chronic active hepatitis. Studies on mechanically and enzymatically isolated rabbit hepatocytes.

Authors:  G Gerken; M Manns; G Ramadori; T Poralla; H P Dienes; K H Meyer zum Büschenfelde
Journal:  J Hepatol       Date:  1987-08       Impact factor: 25.083

6.  Demonstration of binding sites for IgG Fc and the third complement component (C3) on isolated hepatocytes.

Authors:  U Hopf; K H Meyer zum Büschenfelde; M P Dierich
Journal:  J Immunol       Date:  1976-08       Impact factor: 5.422

7.  Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II.

Authors:  U M Zanger; H P Hauri; J Loeper; J C Homberg; U A Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

8.  Anti-LKM-1 antibodies determined by use of recombinant P450 2D6 in ELISA and western blot and their association with anti-HCV and HCV-RNA.

Authors:  R Seelig; M Renz; G Bünger; H Schröter; H P Seelig
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

9.  Anti-liver kidney microsome antibody recognizes a cytochrome P450 from the IID subfamily.

Authors:  M Gueguen; M Meunier-Rotival; O Bernard; F Alvarez
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

10.  Anti-liver-kidney microsome antibody recognizes a 50,000 molecular weight protein of the endoplasmic reticulum.

Authors:  F Alvarez; O Bernard; J C Homberg; G Kreibich
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

View more
  4 in total

1.  Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane.

Authors:  L Muratori; M Parola; A Ripalti; G Robino; P Muratori; G Bellomo; R Carini; M Lenzi; M P Landini; E Albano; F B Bianchi
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

2.  Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease.

Authors:  L Muratori; M Lenzi; Y Ma; M Cataleta; G Mieli-Vergani; D Vergani; F B Bianchi
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

3.  Liver/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis.

Authors:  L Muratori; M Cataleta; P Muratori; M Lenzi; F B Bianchi
Journal:  Gut       Date:  1998-05       Impact factor: 23.059

Review 4.  In vitro analysis of metabolic predisposition to drug hypersensitivity reactions.

Authors:  R J Riley; J S Leeder
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.